United European Gastroenterology Journal

Papers
(The median citation count of United European Gastroenterology Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
123
UEG Week 2021 Oral Presentations118
Medical guidelines must not be influenced by commercial interests98
Table of Contents86
UEG Week 2023 Oral Presentations78
Nodular Regenerative Hyperplasia: Report of 82 Patients and Systematic Review of Literature77
Artificial intelligence: The researcher's assistant or sheep in wolf's clothing?56
Letter of Thanks for UEG Week 2022 Reviewers49
Shedding a new light on gastric cancer screening42
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in Europ39
Stunned by a stone—A curious case of belly trouble34
UEG's prospects for the future34
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study33
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study33
Global Inflammatory Bowel Disease: Opportunities and Challenges for a New Era32
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study32
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response32
Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps31
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 201831
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers31
Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta‐Analysis30
Recent developments in the management of ascites in cirrhosis30
Correction to “Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility”30
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management29
 28
Issue Information28
Correction to “A portrait of Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound training programs in Europe: Current practices and opportunities for improvement”28
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives26
COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry26
Interferential therapy for chronic constipation in adults: The CON‐COUR randomizedcontrolled trial25
Oral Microcapsule Chromocolonoscopy With Patent Blue V Improves Adenoma Detection Safely and Effectively25
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma24
The assessment and management of cirrhotic patients with encephalopathy24
Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study24
Quality of life after endoscopic procedures for chronic pancreatitis: A multicentre study23
T1 colorectal cancer patients' perspective on information provision and therapeutic decision‐making after local resection23
Drug Interaction With Advanced Therapies in Inflammatory Bowel Diseases: A Blind Spot to Tackle22
Non‐Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over‐the‐Counter Medications22
Transcutaneous Auricular Vagal Nerve Stimulation to Treat Chronic Constipation: Another Therapeutic Failure?22
Modifying Our Environment to Improve Outcomes in Inflammatory Bowel Diseases?22
Primary malignant melanoma of the oesophagus22
Association of circulating Z‐polymer with adverse clinical outcomes and liver fibrosis in adults with alpha‐1 antitrypsin deficiency22
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study22
22
Faecal incontinence with concurrent disorders of gut‐brain interaction: A worse outcome21
Irritable bowel syndrome: Factors of importance for disease‐specific quality of life21
Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?21
The Pivotal ‘P’s of inflammatory bowel disease: Prediction and Prevention21
Modifying the natural history of gastrointestinal diseases in Europe as a result of early diagnosis: From eosinophilic esophagitis to inflammatory bowel disease21
Issue Information21
Diagnostic value of radiological staging and surveillance for T1 colorectal carcinomas: A multicenter cohort study20
UEG journal's editorial team20
Leishmaniasis in IBD Patients: Challenges of a Rare Opportunistic Disease19
Prevalence of hepatitis D virus co‐infection in Austria – Finding the needle in the haystack19
Homologous Repair‐Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy19
Issue Information19
Secondary Prophylaxis of Cirrhotic Gastric Variceal Bleeding: Addition of Non‐Selective Beta‐Blockers to Endoscopic Combined Treatment19
Sphingosine‐1‐Phosphate Receptor Modulators for the Treatment of Ulcerative Colitis: A Narrative Review Focusing on Safety19
Environmental risk factors for inflammatory bowel disease18
Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis18
17
Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement17
17
17
Variation in the detection of lymphovascular invasion in T1 colorectal cancer and its impact on treatment: A nationwide Dutch study17
Recent advances in the treatment of refractory gastrointestinal angiodysplasia17
Issue Information17
Sex‐related differences in the presentation, management and response to treatment of eosinophilic esophagitis: Cross sectional analysis of EoE CONNECT registry16
Hepatic Artery Aneurysm Rupture After Double‐Balloon Endoscopy in Biliary Atresia16
Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?16
Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters?16
16
An education‐based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study)16
Chronic and Idiopathic Pancreatitis—A Personalized Treatment Approach15
The Pitfalls of Measuring Burnout Prevalence: μετά the Meta‐Analysis, What Then?15
Response to “Reflections on the Study of Physiological Determinants in Cirrhosis With Ascites”15
A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey15
Pancreatic “supercyst”15
Long‐term outcomes of endoscopic ultrasound‐guided hepaticogastrostomy in patients with malignant biliary obstruction15
Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities15
Increased risk of obstructive lung disease in inflammatory bowel disease: A population‐based cohort study14
14
Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort14
Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Novel Mechanisms and Prevention by Drugs14
Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study14
Incidence, characteristics, and predictive factors of post‐colonoscopy colorectal cancer14
Splenic artery embolisation for splenic injury during colonoscopy: A systematic review14
Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort13
Global trends in opioid use for pain management in acute pancreatitis: A multicentre prospective observational study13
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis13
Gastrointestinal bleeding and endoscopic findings in critically and non‐critically ill patients with corona virus disease 2019 (COVID‐19): Results from Lean European Open Survey on SARS‐CoV‐2 (LEOSS) 13
Gastroenterology Training and Career in Women: Challenges and Opportunities13
Are Education, Socioeconomic Status, and Household Size Dependent Variables Influencing the Developmental Origins of Inflammatory Bowel Disease?13
Multi‐Omics Analysis of Ileal Mucosa and Mesentery Before and After Ileocecal Resection in Crohn's Disease13
The tools at our hand to ensure the highest quality, systematicity, transparency and trustworthiness of clinical practice guidelines13
Intrahepatic splenosis mimicking hepatocellular carcinoma13
Inflammation of the appendix in ulcerative colitis – Does it have a predictive value?13
Challenges with neuropsychiatric Wilson's disease13
Issue Information13
Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?13
Enteroscopic Balloon Dilation in Small Bowel Stricturing Crohn’s Disease: Long‐Term Outcomes and Risk Factors for Surgery in a Single‐Center Prospective Observational Study13
Issue Information12
Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management12
Response to Erdrich S et al.12
Wilson's disease—An early diagnosis to improve outcomes12
UEG week and UEG journal: A strong scientific liaison12
Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis12
New endoscopic tools in inflammatory bowel disease12
Peroral endoscopic myotomy for hypercontractile (Jackhammer) esophagus: A retrospective multicenter series with long‐term follow‐up12
Beyond the numbers: United European Gastroenterology journal's mission to build a community and connect12
Issue Information12
Serum Collagen Biomarkers Are Reflective of Tissue Specific Fibroblasts Associated With Ulcerative Colitis Activity and Treatment Response to Ustekinumab12
New mint on the block – Fresh hope for IBS treatment?12
Endoscopic management of duodenal perforation caused by foreign bodies in adults: A retrospective study12
Effectiveness of Gastric Cancer Endoscopic Screening in Intermediate‐Risk Countries—A Systematic Review and Meta‐Analysis11
European Consensus on Functional Bloating and Abdominal Distension—An ESNM/UEG Recommendations for Clinical Management11
Efficacy of different bowel preparation regimen volumes for colorectal cancer screening and compliance with European Society of Gastrointestinal Endoscopy performance measures11
Clinical relevance of calprotectin in patients with perianal fistulas in Crohn's disease and cryptoglandular fistulas11
Gut Microbial Signatures Associated With Clinical Remission in Inflammatory Bowel Disease Treated With Biologics: A Comprehensive Multi‐Cohort Analysis11
ATG16L1 rs2241880/T300A increases susceptibility to perianal Crohn's disease: An updated meta‐analysis on inflammatory bowel disease risk and clinical outcomes11
A rare case of squamous cell carcinoma originating from esophageal papilloma10
No evidence of association between inherited thrombophilia and increased risk of liver fibrosis10
Four‐fold increased mortality rate in patients with Wilson's disease: A population‐based cohort study of 151 patients10
The unmet need of personalized HCC screening—Lessons learned from the Swedish nationwide registries10
High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong10
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations10
SARS‐Cov‐2 vaccination is safe in autoimmune pancreatitis patients10
Coexistent faecal incontinence and constipation: Common but frequently overlooked10
 10
A stalk with no polyp—A muco‐submucosal elongated polyp in the duodenum10
Overview of a national endoscopy database: The Trans.IT database and its impact on data registration quality10
Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus10
Rare Case of Mantle Cell Lymphoma With Multiple Rectal Lesions9
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort9
9
Best of UEG Week 20249
A Contagious Cause of Rectal Bleeding: Misleading Presentation of Chlamydia trachomatis Infection9
Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and urine: A targeted‐screening analysis case‐control study (PESTIPAC)9
 9
Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males9
Systemic therapies in hepatocellular carcinoma: A revolution?9
Issue Information9
Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history9
Quality of clinical guidelines: It matters as it impacts patient care8
Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery—A UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part I—Sequelae to oncological diseases8
Bugs and germs in GI‐disease8
New insights in the natural course of eosinophilic esophagitis8
Risk factors for the occurrence of ampullary tumors: A case‐control study8
Intra‐abdominal abscesses in CD – When to treat with biologics?8
European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendatio8
8
Re: European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients8
Autoimmune pancreatitis—New evidence for clinical management strategies8
UEG Journal's impact and vision for the future8
Guideline for the diagnosis and treatment of Faecal Incontinence—A UEG/ESCP/ESNM/ESPCG collaboration8
Preclinical IBD: One more piece of the puzzle8
Symptom profiles compatible with disorders of gut‐brain interaction (DGBI) in organic gastrointestinal diseases: A global population‐based study8
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma8
Clinical features and long‐term outcomes of patients with type 2 autoimmune pancreatitis8
UEG Week 2024 Poster Presentations8
Tofacitinib in chronic pouchitis: A step towards addressing an unmet need8
Raising interest for neurogastroenterology: Bottom‐up from the undergraduate medical curriculum?8
Thrombolysis for haemobilia‐induced biliary obstruction through a cholangiodrainage catheter8
Advancing transmural remission as a treatment target in Crohn's disease: The future of tight‐control strategy?7
Evaluation of gastroenterology training curriculum in Greece7
Burden of obesity in gastrointestinal and liver diseases7
Intestinal strictures in Crohn's disease: An update from 20237
Letter to the Editor: How to raise the interest for neurogastroenterology among young gastroenterologists?7
The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis7
Adiposity as a risk factor for inflammatory bowel disease and the mediating effect of metabolic and inflammatory status: A population‐based cohort study7
Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education7
Acute decompensation of cirrhosis versus acute‐on‐chronic liver failure: What are the clinical implications?7
Response to Letter to the Editor7
Hearing what isn't said7
In memoriam: Rolf Hultcrantz (1949–2022)7
Towards a robust and compact deep learning system for primary detection of early Barrett’s neoplasia: Initial image‐based results of training on a multi‐center retrospectively collected data set7
External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3‐F4 patients7
Endoscopists performance in optical diagnosis of colorectal polyps in artificial intelligence studies7
Ulcerative colitis increases risk of hypertension in a UK biobank cohort study7
Endoscopy‐Related Musculoskeletal Injuries: A Systematic Review and Meta‐Analysis on Prevalence, Risk Factors and Prevention7
Tofacitinib for the treatment of chronic pouchitis: A pilot study7
Young GI Angle: The young perspective of the UEG White Book 2 by the Friends of the UEG Young Talent Group7
UEG journal: The voice of European Gastroenterology7
Natural course of ulcerative colitis in China: Differences from the West?7
5G‐based remote magnetically controlled capsule endoscopy for examination of the stomach and small bowel7
Computer‐aided diagnosis in real‐time endoscopy for all stages of gastric carcinogenesis: Development and validation study7
Darvadstrocel for complex perianal fistulas in Crohn's disease: A systematic review and meta‐analysis7
Cost–effectiveness of pancreatic cancer screening: Time for a more tailored approach6
Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes6
Colorectal polyps: Targets for fluorescence‐guided endoscopy to detect high‐grade dysplasia and T1 colorectal cancer6
Indeterminate pediatric acute liver failure: Clinical characteristics of a temporal cluster of five children in the Netherlands in the spring of 20226
Issue Information6
Gastric emptying rate and relevance for symptoms6
Clinical management of chronic hepatitis B: A concise overview6
Atezolizumab and bevacizumab for non‐resectable or metastatic combined hepatocellular‐cholangiocarcinoma: A multicentric retrospective study6
Patient and First‐Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease—A Multinational Survey6
Correction6
An artificial intelligence‐driven scoring system to measure histological disease activity in ulcerative colitis6
Prior metabolic and bariatric surgery is an independent determinant of severity of decompensation in alcohol‐associated liver disease6
Training Allied Healthcare Professionals Maybe the Answer to Upscaling Gut‐Directed Hypnotherapy6
Towards a Greener IBD‐Care: Let's INTERACT!6
SARS‐CoV‐2 and immunosuppressors at cellular level: Some good news6
Clinical usefulness of scoring systems to predict severe acute pancreatitis: A systematic review and meta‐analysis with pre and post‐test probability assessment6
Environmental and Inflammatory Factors Drive Perinuclear‐Antineutrophil Cytoplasmic Antibodies (pANCA) in Ulcerative Colitis: A European Twin Study6
Pancreatic cancer surveillance: Risk stratification of individuals with a germline CDKN2A pathogenic variant6
Validation of stricture length, duration and obstructive symptoms as predictors for intervention in ileal stricturing Crohn's disease6
Nurse‐Administered Gut‐Directed Hypnotherapy for Irritable Bowel Syndrome: A Two‐Year Follow‐Up Study6
A NECessary Workup: Exploring the Rare Histology of an Esophageal Tumor6
Acute psychological stress increases paracellular permeability and modulates immune activity in rectal mucosa of healthy volunteers6
Composite Lymphoma: A Rare Case of Vomiting5
Fecal and Serum Metabolome in Crohn’s Disease is Linked With Future Flare5
Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes5
UEG Week 2022 Moderated Posters5
Endoscopic retrograde cholangiopancreatography training conditions, results from a pan‐European survey: Between vision and reality5
COVID‐19 and digestive health: Implications for prevention, care and the use of COVID‐19 vaccines in vulnerable patients5
Issue Information5
Comparison between tofacitinib and ustekinumab as a third‐line therapy in refractory ulcerative colitis: A multicenter international study5
Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit5
Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease5
Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study5
UEG Week 2023 Poster Presentations5
Advancing patient‐centered care: Recent developments in UEG's patient relations5
Changing paradigms in management of inflammatory bowel disease5
Manometric identikit of a functioning and effective fundoplication for gastroesophageal reflux disease in the high‐resolution manometry ERA5
Vedolizumab for Crohn's disease: Real‐world efficacy through a meta‐analytical lens5
Identifying predictors for comorbidities related mortality versus pancreatic cancer related mortality in patients with intraductal papillary mucinous neoplasm5
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease5
5
Workup and management of liver transplantation in alcohol‐related liver disease5
Surfing the web as a patient with IBD: New horizons5
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?4
Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross‐sectional observational study4
Addressing the overlooked psychological and social impact of fecal incontinence in inflammatory bowel disease patients4
Issue Information4
Therapeutic management of metabolic dysfunction associated steatotic liver disease4
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression4
Recurrent symptoms after achalasia treatment: The value of impedance analysis4
Transplanting severely obese cirrhotic patients: Heavy clouds still on the horizon4
Health aspects of faecal incontinence are complex and multi‐layered4
High vaccination coverage and infection rate result in a robust SARS‐CoV‐2‐specific immunity in the majority of liver cirrhosis and transplant patients: A single‐center cross‐sectional study4
Acknowledgements4
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis4
Understanding progression of strictures in ileal Crohn's disease—The importance of setting methodological standards4
Organoid‐based precision medicine in pancreatic cancer4
Incidence and Management of Splanchnic Vein Thrombosis in Pancreatic Diseases4
Tonsillar Crohn's Disease4
4
Issue Information4
4
Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform4
0.17295908927917